Neha Krishnamohan joined our board of directors in September 2022. Ms Krishnamohan is currently the chief financial officer and executive vice president of corporate development at Kinnate Biopharma, with over 12 years of experience in healthcare investment banking and finance. Previously, Ms Krishnamohan was the vice president in the Healthcare Investment Banking Group and a member of the Mergers and Acquisitions (M&A) Group within the Investment Banking Division at Goldman Sachs While at Goldman Sachs, she established herself as a senior leader in the healthcare coverage group, working with a variety of biopharmaceutical boards and management teams on a broad range of strategic financial matters, executing financings as well as leading M&A transactions. Of note, she was one of the lead bankers on Arcutis’ highly successful 2020 initial public offering. Ms Krishnamohan has successfully executed over $100 billion in transactions in the biopharmaceutical, medical technology, and tools/diagnostics sectors. Ms Krishnamohan holds a BSE with a double major in Biomedical Engineering and Economics from Duke University.